Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Biology and function of CDKs

EONS 10

17 - 18 Oct 2016

Sorry, this item is currently unavailable.

Published: 15 Nov 2016

Rating:

Save

Dr Ghadeer Shubassi - Institute of Molecular Oncology, Milan, Italy

Dr Ghadeer Shubassi speaks at EONS 10 about the role of cyclins and cyclin dependent kinases in healthy cells, and how this informs drug design for treatment of cancer

CDKs were also discussed at an ecancer symposium at ESMO 2016.

Supported by a grant from Pfizer Inc.

Related Videos

ASCO GU 2026: Updates in bladder cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina

17 Mar 2026

Made to measure: Choosing the optimal regimen in transplant-eligible NDMM

Dr Elias Mai - Heidelberg University, Heidelberg, Germany

28 Oct 2024

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg

15 Sep 2024

Addressing the rise of multiple myeloma in Rwanda

Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda

6 Aug 2024

Hormonal receptor positive breast cancer adjuvant and metastatic indications

Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA

12 Jul 2024

ASCO 2024: Lung cancer highlights

Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas Girard and Dr Anna Minchom

26 Jun 2024

Multiple myeloma in a resource constrained setting

Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda

22 Feb 2024

OncoAlert round up July 28th to August 3rd, 2023

Dr Gil Morgan - Executive Director, OncoAlert

4 Aug 2023

Molecular oncology and translational medicine

Dr Gregg Fields - Florida Atlantic University, Florida, USA

7 Jul 2023

Biology and function of CDKs

EONS 10

Related Videos

More from ecancer